Apr 09, 2014 12:21 PM EDT
WHO Seeks to Lower the Price of New Hepatitis C Drug, Sovaldi
Gilead Sciences’ new hepatitis C drug, Sovaldi, will cost $84,000 for a 12-week treatment plan, rounding out to $1,000 a day. Bound to cause a whirlwind among investors and the healthcare world, the World Health Organization has stepped in.